Burton’s appointment ushers in a bold new era for DRIF, the fundraising arm of the premier cure-based research institute Michael Burton, CEO, Diabetes Research Institute Foundation MIAMI (July 17, 2023) – The Diabetes Research Institute Foundation (DRIF), the...
This year, the DRI entered into a new partnership with iTolerance, a Miami-based early-stage regenerative medicine company, with a promising new therapy in development for individuals with type 1 diabetes. The company’s lead platform technology, iTOL-100, is a...
One of the world’s leading diabetes experts, Matthias von Herrath, M.D., has been named the new scientific director of the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine. Dr. von Herrath takes over the lead position at the...
Recent Comments